Lanfear Capital
Lanfear Capital is a venture capital firm based in Palo Alto, California, that focuses on seed and early-stage investments primarily within the therapeutic, device, and biopharma sectors. The firm seeks investment opportunities where it can contribute beyond just financial support, actively engaging with entrepreneurs and management teams to address challenges and enhance value creation. With decades of experience and extensive industry relationships, Lanfear Capital aims to foster dynamic partnerships that align interests in building sustainable growth. The firm's operating philosophy emphasizes capability, integrity, and professionalism, and it also invests in select venture funds that share its approach.
InteKrin Therapeutics is a clinical-stage, privately held BioPharma company focused on developing and commercializing breakthrough therapeutics for neuroendocrine, metabolic, and immune disorders. Diseases such as diabetes, metabolic syndrome, and cancer are increasingly in need of novel treatments that provide patients with better treatment alternatives and help to curb soaring healthcare costs. The company is in the process of in-licensing early- and late-stage compounds that have the potential to unlock the complex hormonal relationship between metabolism, insulin resistance, and obesity.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.